Sleep Dysfunction In Neurodegeneration plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Sleep Dysfunction In Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Sleep disturbances are common in neurodegenerative diseases and often precede motor and cognitive symptoms. Sleep dysfunction contributes to disease progression and significantly impacts quality of life.
- NREM (N1-N3): Slow wave sleep, restorative
- REM: Dreaming, memory consolidation
- Circadian rhythms: 24-hour sleep-wake cycle
- Suprachiasmatic nucleus: Master clock
- Ventrolateral preoptic area: Sleep-promoting
- Tuberomammillary nucleus: Wake-promoting
- Orexin/hypocretin neurons: Arousal regulation
- Sleep fragmentation: Common early feature
- REM sleep behavior disorder: May precede dementia
- Circadian disruption: Evening agitation
- Amyloid deposition: Sleep-dependent clearance
- REM sleep behavior disorder: Common early marker
- Excessive daytime sleepiness: Non-motor symptom
- Insomnia: Frequent complaint
- Sleep apnea: Increased prevalence
- Sleep fragmentation: Early abnormality
- Reduced REM: Altered architecture
- Circadian disruption: Gene effects
- Sleep-disordered breathing: Respiratory involvement
- Insomnia: Common
- Restless legs syndrome: Associated
- Brainstem involvement: Sleep center disruption
- Orexin loss: Narcolepsy-like symptoms
- Circadian clock damage: SCN vulnerability
- α-Synuclein: Affects sleep centers
- Tau pathology: Disrupts neural circuits
- Sleep-wake circuits: Direct effects
- Cytokine effects: Sleep regulation
- Microglial activation: Alters sleep
- Systemic inflammation: Contributes
- GABA deficits: Sleep disruption
- Serotonin alterations: REM regulation
- Dopaminergic changes: Motor and sleep
- Melatonin therapy: Circadian entrainment
- Orexin antagonists: Sleep promotion
- Cognitive behavioral therapy: Sleep hygiene
- Bright light therapy: Circadian alignment
- Respiratory support: Sleep apnea treatment
Sleep Dysfunction In Neurodegeneration plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Sleep Dysfunction In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Wulff K, et al. (2010). Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease. Nat Rev Neurosci. PMID:20725095.
- Ju YE, et al. (2013). Sleep and neurodegeneration. JAMA Neurol. PMID:23553344.
- Tremblay C, et al. (2020). Sleep and Alzheimer's disease. Sleep Med Clin. PMID:32883637.
- Videnovic A, et al. (2014). Circadian alterations in Parkinson's disease. J Neural Transm. PMID:23900734.
- Zhang F, et al. (2021). Sleep dysfunction in neurodegenerative diseases. Nat Rev Neurol. PMID:34239130.
- Malhotra RK, Avidan AY. (2014). Sleep stages and neurodegeneration. Continuum. PMID:25439244.
- Boeve BF. (2010). REM sleep behavior disorder. Ann N Y Acad Sci. PMID:20590420.
- Barone P, et al. (2014). Parkinson's disease sleep disorder. Parkinsonism Relat Disord. PMID:24332456.
🔴 Low Confidence
| Dimension |
Score |
| Supporting Studies |
8 references |
| Replication |
0% |
| Effect Sizes |
25% |
| Contradicting Evidence |
0% |
| Mechanistic Completeness |
75% |
Overall Confidence: 36%